A pooled analysis reveals novel manifestations of pembrolizumab-induced sarcoidosis-like immune-related adverse events, particularly affecting phosphocalcic metabolism. This study aggregates published cases to enhance understanding of these rare side effects.
pembrolizumab induced sarcoidosis like immune related adverse events a pooled analysis of published cases and report of a novel manifestation involving phosphocalcic metabolism
Original title: “Pembrolizumab-Induced Sarcoidosis-Like Immune-Related Adverse Events: A Pooled Analysis of Published Cases and Report of a Novel Manifestation Involving Phosphocalcic Metabolism.”